Journal
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Volume 16, Issue 2, Pages 211-227Publisher
BAILLIERE TINDALL
DOI: 10.1053/berh.2001.0222
Keywords
systemic lupus erythematosus; cardiopulmonary manifestations; pleurisy; pericarditis; coronary artery disease
Categories
Funding
- NIAMS NIH HHS [1-P60-AR-44811, K24 AR02213-01, R01 AR46588-01] Funding Source: Medline
Ask authors/readers for more resources
Systemic lupus erythematosus (SLE) is a connective tissue disease characterized by the formation of autoantibodies and immune complexes. The heart and lungs are among the organ systems commonly affected in SLE. Pericarditis, premature coronary atherosclerosis, pleuritis and pulmonary infections are the most prevalent cardiopulmonary manifestations. Other rare associations include myocarditis, coronary arteritis, acute lupus pneumonitis/pulmonary haemorrhage, acute reversible hypoxaemia and 'shrinking lung' syndrome. Current imaging modalities may provide earlier detection of subclinical disease, which may aid in preventing these potentially fatal complications. The response to treatment varies, depending on the presentation of disease. In this chapter we address the frequency, diagnosis and monitoring, and treatment regimens of cardiac and pulmonary involvement in patients with SLE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available